Cholelithiasis
Conditions
Interventions
Control group (fiberoptic cholangioscopy group):Fiberoptic cholangioscopy
Test group (digital cholangioscopy group):Digital cholangioscopy
Sponsors
Zhujiang Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Men or wome,18 to 75 years old. 2. Persons that fibrobiliary endoscope examinations or treatments are in need. 3. Persons that are voluntary to participate in this clinical trial, with written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with cirrhosis ascites. 2. Patients with bleeding tendencies. 3. Patients with unstable or complicated diseases, including acute biliary tract infections, organ failures, malignant tumors, and hypoproteinemia (albumin <30g/L). 4. Pregnant or lactating women. 5. Patients with mental illness. 6. Patients that have participated in other clinical trials 30 days before the enrollment. 7. Patients that are not appropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The image quality compliance rate for clinical diagnostic requirement (center evaluation); | — |
Secondary
| Measure | Time frame |
|---|---|
| Instrument performance score;Instrument safety evaluation; | — |
Countries
China
Contacts
Public ContactKebo Zhong; Yi Gao
Zhujiang Hospital of Southern Medical University
Outcome results
None listed